Literature DB >> 19300877

Structural imaging markers for therapeutic trials in Alzheimer's disease.

N C Fox1, J Kennedy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19300877     DOI： 10.1007/s12603-009-0040-y

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN： 1279-7707            Impact factor:   4.075


× No keyword cloud information.
  13 in total

1.  Combining short interval MRI in Alzheimer's disease: Implications for therapeutic trials.

Authors:  J M Schott; C Frost; J L Whitwell; D G Macmanus; R G Boyes; M N Rossor; N C Fox
Journal:  J Neurol       Date:  2006-09-22       Impact factor: 4.849

2.  Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.

Authors:  Jonathan H Morra; Zhuowen Tu; Liana G Apostolova; Amity E Green; Christina Avedissian; Sarah K Madsen; Neelroop Parikshak; Arthur W Toga; Clifford R Jack; Norbert Schuff; Michael W Weiner; Paul M Thompson
Journal:  Neuroimage       Date:  2008-11-08       Impact factor: 6.556

3.  MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD.

Authors:  R S Desikan; B Fischl; H J Cabral; T L Kemper; C R G Guttmann; D Blacker; B T Hyman; M S Albert; R J Killiany
Journal:  Neurology       Date:  2008-07-30       Impact factor: 9.910

4.  Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects.

Authors:  N C Fox; S Cousens; R Scahill; R J Harvey; M N Rossor
Journal:  Arch Neurol       Date:  2000-03

5.  Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.

Authors:  D P Devanand; G Pradhaban; X Liu; A Khandji; S De Santi; S Segal; H Rusinek; G H Pelton; L S Honig; R Mayeux; Y Stern; M H Tabert; M J de Leon
Journal:  Neurology       Date:  2007-03-13       Impact factor: 9.910

6.  Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression.

Authors:  Basil H Ridha; Valerie M Anderson; Josephine Barnes; Richard G Boyes; Shona L Price; Martin N Rossor; Jennifer L Whitwell; Lisa Jenkins; Ronald S Black; Micheal Grundman; Nick C Fox
Journal:  J Neurol       Date:  2008-02-18       Impact factor: 4.849

7.  Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.

Authors:  C R Jack; M M Shiung; J L Gunter; P C O'Brien; S D Weigand; D S Knopman; B F Boeve; R J Ivnik; G E Smith; R H Cha; E G Tangalos; R C Petersen
Journal:  Neurology       Date:  2004-02-24       Impact factor: 9.910

8.  Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.

Authors:  N C Fox; R S Black; S Gilman; M N Rossor; S G Griffith; L Jenkins; M Koller
Journal:  Neurology       Date:  2005-05-10       Impact factor: 9.910

9.  Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months.

Authors:  J M Schott; S L Price; C Frost; J L Whitwell; M N Rossor; N C Fox
Journal:  Neurology       Date:  2005-07-12       Impact factor: 9.910

10.  Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study.

Authors:  Basil H Ridha; Josephine Barnes; Jonathan W Bartlett; Alison Godbolt; Tracey Pepple; Martin N Rossor; Nick C Fox
Journal:  Lancet Neurol       Date:  2006-10       Impact factor: 44.182
View more
  5 in total

1.  Imaging and biomarkers will be used for detection and monitoring progression of early Alzheimer's disease.

Authors:  M W Weiner
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

Review 2.  The clinical use of structural MRI in Alzheimer disease.

Authors:  Giovanni B Frisoni; Nick C Fox; Clifford R Jack; Philip Scheltens; Paul M Thompson
Journal:  Nat Rev Neurol       Date:  2010-02       Impact factor: 42.937

3.  Use of biomarkers in Alzheimer's trials.

Authors:  B Vellas
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

4.  Head-to-head comparison of two popular cortical thickness extraction algorithms: a cross-sectional and longitudinal study.

Authors:  Alberto Redolfi; David Manset; Frederik Barkhof; Lars-Olof Wahlund; Tristan Glatard; Jean-François Mangin; Giovanni B Frisoni
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

5.  Effects of aerobic exercise on cognition and hippocampal volume in Alzheimer's disease: study protocol of a randomized controlled trial (The FIT-AD trial).

Authors:  Fang Yu; Ulf G Bronas; Suma Konety; Nathaniel W Nelson; Maurice Dysken; Clifford Jack; Jean F Wyman; David Vock; Glenn Smith
Journal:  Trials       Date:  2014-10-11       Impact factor: 2.279
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.